T2 Biosystems strong buy rating!

..mit KZ 12 USD

http://www.finanzen.net/analyse/...s_Strong_Buy-WBB_Securities_584226

About:

http://www.t2biosystems.com/pipeline/

Aktueller Kurs: 5,29 USD +0,31 USD +6,22 %

 

MK 25 Mio. $  

siehe #73  

http://ih.advfn.com/...p;width=800&vol=1&height=400&Vol=1  

T2Bacteria Identifies Causative Pathogen in a Critically Ill Patient with a Respiratory Infection

https://www.t2biosystems.com/...patient-with-a-respiratory-infection/

 

siehe #60/#70/#73  

T2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient, Inc.

https://finance.yahoo.com/news/...multiyear-innovative-120010744.html  

Hackensack Meridian Health's Center for Discovery and Innovation COVID-19 Test Licensed to T2 Biosystems for Widespread Deployment

https://www.prnewswire.com/news-releases/...deployment-301029255.html

...Under this agreement, T2 Biosystems is authorized to adapt the CDI-developed COVID-19 test to the T2 Biosystems platform, and market and distribute the test in places of need amid the expanding pandemic...  

 

https://old.nasdaq.com/de/symbol/ttoo/real-time

Mittlerweile gibt`s nur fast 100 Biotechs die allesamt mehr oder weniger mit Covid 19 zu tun haben (wollen). Am Ende ziehen aber nur Wenige das große Los. Also aufpassen!  

New COVID-19 assay will be adapted to run on T2 Biosystems? FDA-cleared T2Dx® Instrument

https://t2biosystems.gcs-web.com/news-releases/...-agreement-covid-19  

Test auf einem T2 System laufen zulassen finde ist das schon eine Hammernews.  

Coronaviren feststellen will. Die Krankheit befällt Rachen und Atemwege sowie die Lunge. Aber natürlich nette Möglichkeit, Aufmerksamkeit auf das eigenen System zu lenken.  

es Bluttest die das nachweisen!

https://www.biospace.com/article/releases/...coronavirus-sars-cov-2-/

 

Assay gepaart mit der T2 Technologie und dem neuen Technologievertrag von Vizient ist schon grandios, IMO.  

https://fintel.io/s/us/...p;utm_medium=Social&utm_campaign=filing
 

eine rolle ob ich an der Nasdaq Börse oder in DE kaufe?  

Bitte anschnallen, wir wollen starten!  

Motorschaden, glaube nicht, dass wir die 1 heute nochmal sehen werden  

 

ich doch , das wird nicht reichen für $1  

plumper Versuch die Corona-Welle zu reiten

"T2 Biosystems recently announced a licensing agreement to support development of a rapid COVID-19 test..."

die vorläufigen Q1/20 Zahlen sind schlecht:

• Umsatz 2,2-2,6 Mio. $
  
  • davon 0,9-1,1 Mio. $ Produktumsätze (Q1/19 ~ 1,3 Mio. $)
    
• keine Prognose für 2020 (wegen Corona)
  

Würde mich nicht wundern, wenn wir hier bald eine Kapitalerhöhung sehen würden.

http://investors.t2biosystems.com/news-releases/...ter-2020-financial

 

In der von der zitierten Quelle steht aber weiters auch das:

"T2 Biosystems intends to adapt the newly licensed COVID-19 test to run on its T2Dx® Instrument, the same instrument used for the FDA-cleared T2Bacteria® and T2Candida® Panels, allowing the detection of both coronavirus and associated secondary bacterial or fungal infections that may lead to sepsis. "  

LEXINGTON, Mass., March 24, 2020 (GLOBE NEWSWIRE)?T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced unaudited, preliminary financial result estimates for the quarter ended March 31, 2020, and suspended full year2020 financial and operational guidance due to uncertainties from the impact of the novel coronavirus (COVID-19) pandemic.

The Company continues to leverage its technology and scientific expertise to aid in the COVID-19 response while prioritizing the health and safety ofits employees and customers. T2 Biosystems recently announced a licensing agreement to support development of a rapid COVID-19 test, developed bythe Center of Discovery and Innovation (CDI) at Hackensack Meridian Health, enabling a larger role in the pandemic response.

The licensed coronavirus assay has been used by healthcare professionals within the Hackensack Meridian Health network, under the U.S. Food andDrug Administration?s Emergency Use Authorization guidance, to test and treat patients suspected of having coronavirus. T2 Biosystems intends toadapt the newly licensed COVID-19 test to run on its T2Dx® Instrument, the same instrument used for the FDA-cleared T2Bacteria® and T2Candida®Panels, allowing the detection of both coronavirus and associated secondary bacterial or fungal infections that may lead to sepsis.

 

http://ih.advfn.com/...p;width=800&vol=1&height=400&Vol=1  

POWER HOUR GO TO DOWN